Jazz Pharmaceuticals (JAZZ) Enterprise Value (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Enterprise Value of -$1.8 billion for Q1 2026, up 0.95% year-over-year from -$1.8 billion in Q1 2025, and down 32.5% quarter-over-quarter from -$1.4 billion in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Enterprise Value (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Enterprise Value history runs 17 years deep, the most recent figure standing at -$1.8 billion for Q1 2026.
- In Q1 2026, Enterprise Value rose 0.95% year-over-year to -$1.8 billion; the TTM figure through Mar 2026 stood at -$1.8 billion (up 0.95% YoY), while the FY2025 annual figure was -$1.4 billion, up 42.31% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.8 billion, down from -$1.4 billion in the prior quarter.
- The five-year high for Enterprise Value was -$490.8 million in Q1 2022, with the low at -$2.4 billion in Q4 2024.
- The 5-year median for Enterprise Value is -$1.3 billion (2023), against an average of -$1.4 billion.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value jumped 76.6% in 2022, then slumped 137.94% in 2023.
- Jazz Pharmaceuticals' Enterprise Value stood at -$881.5 million in 2022, then sank by 70.88% to -$1.5 billion in 2023, then slumped by 60.18% to -$2.4 billion in 2024, then jumped by 42.31% to -$1.4 billion in 2025, then tumbled by 32.5% to -$1.8 billion in 2026.
- Business Quant data shows JAZZ's Enterprise Value at -$1.8 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | -1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.62 Bn |
| Mar 31, 2026 | -1.84 Bn |
| Dec 31, 2025 | -1.39 Bn |
| Sep 30, 2025 | -1.33 Bn |
| Jun 30, 2025 | -1.19 Bn |
| Mar 31, 2025 | -1.86 Bn |
| Dec 31, 2024 | -2.41 Bn |
| Sep 30, 2024 | -2.22 Bn |
| Jun 30, 2024 | -1.36 Bn |
| Mar 31, 2024 | -1.44 Bn |
| Dec 31, 2023 | -1.51 Bn |
| Sep 30, 2023 | -1.34 Bn |
| Jun 30, 2023 | -1.28 Bn |
| Mar 31, 2023 | -1.17 Bn |
| Dec 31, 2022 | -881.48 Mn |
| Sep 30, 2022 | -839.36 Mn |
| Jun 30, 2022 | -711.27 Mn |
| Mar 31, 2022 | -490.84 Mn |
| Dec 31, 2021 | -591.45 Mn |
| Sep 30, 2021 | -671.78 Mn |